185 related articles for article (PubMed ID: 17120184)
1. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro.
de Gortázar AR; Alonso V; Alvarez-Arroyo MV; Esbrit P
Calcif Tissue Int; 2006 Nov; 79(5):360-9. PubMed ID: 17120184
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
Alonso V; de Gortázar AR; Ardura JA; Andrade-Zapata I; Alvarez-Arroyo MV; Esbrit P
J Cell Physiol; 2008 Dec; 217(3):717-27. PubMed ID: 18651620
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
4. C-terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells.
Martínez ME; García-Ocaña A; Sánchez M; Medina S; del Campo T; Valin A; Sanchez-Cabezudo MJ; Esbrit P
J Bone Miner Res; 1997 May; 12(5):778-85. PubMed ID: 9144344
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-6/soluble interleukin-6 receptor system induces parathyroid hormone-related protein in human osteoblastic cells.
Guillén C; de Gortázar AR; Esbrit P
Calcif Tissue Int; 2004 Aug; 75(2):153-9. PubMed ID: 15129368
[TBL] [Abstract][Full Text] [Related]
6. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
[TBL] [Abstract][Full Text] [Related]
7. Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function.
García-Martín A; Acitores A; Maycas M; Villanueva-Peñacarrillo ML; Esbrit P
J Cell Biochem; 2013 Jun; 114(6):1404-13. PubMed ID: 23444047
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
9. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
10. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
Son E; Do H; Joo HM; Pyo S
Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
[TBL] [Abstract][Full Text] [Related]
11. Effects of PTH on PTHrP gene expression in human osteoblasts: up-regulation with the kinetics of an immediate early gene.
Walsh CA; Bowler WB; Bilbe G; Fraser WD; Gallagher JA
Biochem Biophys Res Commun; 1997 Oct; 239(1):155-9. PubMed ID: 9345287
[TBL] [Abstract][Full Text] [Related]
12. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.
Lozano D; Feito MJ; Portal-Núñez S; Lozano RM; Matesanz MC; Serrano MC; Vallet-Regí M; Portolés MT; Esbrit P
Acta Biomater; 2012 Jul; 8(7):2770-7. PubMed ID: 22487933
[TBL] [Abstract][Full Text] [Related]
13. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
14. C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells.
Esbrit P; Alvarez-Arroyo MV; DE Miguel F; Martin O; Martinez ME; Caramelo C
J Am Soc Nephrol; 2000 Jun; 11(6):1085-1092. PubMed ID: 10820172
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein is required for normal intramembranous bone development.
Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
[TBL] [Abstract][Full Text] [Related]
17. In vitro regulation of proliferation and differentiation within a postnatal growth plate of the cranial base by parathyroid hormone-related peptide (PTHrP).
Wealthall RJ
J Cell Physiol; 2009 Jun; 219(3):688-97. PubMed ID: 19229881
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of G11alpha in osteoblastic cells enhances parathyroid hormone activation of phospholipase C and AP-1 regulation of matrix metalloproteinase-13 mRNA.
Cheung R; Erclik MS; Mitchell J
J Cell Physiol; 2005 Jul; 204(1):336-43. PubMed ID: 15693018
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells.
Valín A; García-Ocaña A; De Miguel F; Sarasa JL; Esbrit P
J Cell Physiol; 1997 Feb; 170(2):209-15. PubMed ID: 9009150
[TBL] [Abstract][Full Text] [Related]
20. Endogenous parathyroid hormone-related peptide enhances proliferation and inhibits differentiation in the osteoblast-like cell line ROS 17/2.8.
Du P; Ye Y; Seitz PK; Bi LG; Li H; Wang C; Simmons DJ; Cooper CW
Bone; 2000 May; 26(5):429-36. PubMed ID: 10773581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
